BridgeMD
New treatment option for Chronic Stroke
Official title Effect of NMES on Balance and Fall Risk in Chronic Stroke
ClinicalTrials.gov ID: NCT04957355
What this study is testing
- What it's testing
- The aim of this study is to describe the effect of neuromuscular electrical stimulation (NMES) in the form of functional electrical stimulation (FES) applied to different lower limb muscles on reactive balance and gait performance in stroke participants. Methods: Twenty individuals with chronic stroke will be asked to perform an experimental protocol that includes a postural disturbance in the form of a slip- or trip-like perturbation and a standardized walking test in both laboratory and outdoor environments with and without FES applied to different lower limb muscles of the paretic leg.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Age group: 18-90 years.
- Presence of hemiparesis.
- Onset of stroke (\> 6 months).
- Ability to walk independently with or without an assistive device for at least 300 ft.
- Can understand and communicate in English.
You likely can't join if
- people will not proceed with the test if any of the following occurs at baseline measurement: 1) HR \> 85% of age-predicted maximal heart rate...
- Body weight more than 250 lbs.
- Any neurological condition other than stroke.
- Any cardiopulmonary, musculoskeletal, or systemic diagnosis.
- Recent major surgery (\< 6 months) or hospitalization (\< 3 months).
- Deep venous thrombosis.
See the full eligibility criteria
- Age group: 18-90 years.
- Presence of hemiparesis.
- Onset of stroke (\> 6 months).
- Ability to walk independently with or without an assistive device for at least 300 ft.
- Can understand and communicate in English.
- Cognitively and behaviorally capable of complying with the regimen (Montreal Cognitive Assessment \> 25/30).
- people will not proceed with the test if any of the following occurs at baseline measurement: 1) HR \> 85% of age-predicted maximal heart rate (HRmax) (HRmax = 220 - age), 2) systolic blood pressure (SBP) \> 165 mmHg...
- Body weight more than 250 lbs.
- Any neurological condition other than stroke.
- Any cardiopulmonary, musculoskeletal, or systemic diagnosis.
- Recent major surgery (\< 6 months) or hospitalization (\< 3 months).
- Deep venous thrombosis.
- Antecedent of cancer.
- Peripheral nerve injury or neuropathy in the affected limb with motor disability.
- Spasticity (Ashworth scale \> 2).
- Uncontrolled high blood pressure/angina.
- Skin condition not tolerant with FES therapy.
- Uncontrolled seizure disorder.
- Botox treatment within the last 5 months.
- History of epilepsy.
- Pacemaker users. Excluded or Vulnerable Populations Non-English speaking populations will be excluded as the consent procedures and instructions will be in English.
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.